Champions Oncology, Inc. SEC filings CSBR

Champions Oncology, Inc. has 655 filings in SEC EDGAR's recent list, going back to Sep 13, 1995. Its latest annual report, Form 10-K, was filed on Jul 27, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 11, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (shareholder vote results). The company's fiscal year ends on April 30.

Champions Oncology, Inc. SEC filings
Form Description Filed Period
10-K Annual report Jul 27, 2026 Apr 30, 2026
10-K Annual report Jul 23, 2025 Apr 30, 2025
10-K Annual report Jul 19, 2024 Apr 30, 2024
10-K Annual report Jul 24, 2023 Apr 30, 2023
10-K Annual report Jul 22, 2022 Apr 30, 2022
10-K Annual report Jul 26, 2021 Apr 30, 2021
10-K Annual report Jul 28, 2020 Apr 30, 2020
10-K Annual report Jul 29, 2019 Apr 30, 2019
10-K Annual report Jul 30, 2018 Apr 30, 2018
10-K Annual report Jul 28, 2017 Apr 30, 2017
10-K Annual report Jul 29, 2016 Apr 30, 2016
10-K Annual report Jul 29, 2015 Apr 30, 2015
10-K Annual report Jul 28, 2014 Apr 30, 2014
10-K Annual report Jul 26, 2013 Apr 30, 2013
10-K Annual report Jul 18, 2012 Apr 30, 2012
10-K/A Amended annual report Mar 13, 2012 Apr 30, 2011
10-K Annual report Jul 15, 2011 Apr 30, 2011
10-K Annual report Jul 28, 2010 Apr 30, 2010
10-K Annual report Aug 27, 2009 Apr 30, 2009
10-K/A Amended annual report Aug 27, 2009 Apr 30, 2008

Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CSBR (Nasdaq)
Fiscal year ends
April 30
Incorporated in
DE
Headquarters
Baltimore, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
771856
Former names
CHAMPIONS BIOTECHNOLOGY, INC. (until Mar 30, 2011); CHAMPIONS SPORTS INC (until Feb 16, 2007)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.